Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAAs in HCV-negative recipients of HCV-positive organ transplants
NCT03702218Phase 1Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2019
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial in hepatitis C (HCV) (3 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Sustained Virologic Response at 12 months. Planned start Jul 2019; status: withdrawn.
02
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03702218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702218.